Join to View Full Profile
3400 Civic Center BlvdPhiladelphia, PA 19104
Phone+1 215-662-2300
Fax+1 215-349-8529
Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amna Khan is an endocrinologist in Philadelphia, PA and is affiliated with Hospital of the University of Pennsylvania. She received her medical degree from King Edward Medical University and has been in practice 16 years. She specializes in osteoporosis and metabolic bone disorders.
Education & Training
University of TennesseeFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2005 - 2007
King Edward Medical UniversityClass of 2001
Certifications & Licensure
PA State Medical License 2014 - 2026
LA State Medical License 2009 - 2015
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014, 2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2017
Publications & Presentations
PubMed
- Can Trabecular Bone Score Enhance Fracture Risk Assessment in Long-Distance Runners With Bone Stress Injuries?Rashad Madi, Sarem Khan, Chamith S Rajapakse, Amna N Khan, Kate Temme
Clinical Journal of Sport Medicine. 2025-03-01 - 3 citationsTrends in hip fracture rates in US male veterans.Amna N Khan, Robert B Jones Jr, Nabeel Khan, Yu-Xiao Yang, Robert A Adler
Osteoporosis International. 2024-12-01 - 4 citationsValidation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer.John K Lin, Caleb M Hearn, Emily Getzen, Qi Long, David C Lee
European Urology Oncology. 2024-08-01
Professional Memberships
- 0
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
